Parnell Pharmaceuticals Holdings
Alexandria
New South Wales
52 articles about Parnell Pharmaceuticals Holdings
-
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
1/6/2023
Parnell Pharmaceuticals Holdings Ltd announced the extension of the backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
-
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering
12/6/2022
Parnell Pharmaceuticals Holdings Ltd commenced its previously announced backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
-
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering
12/2/2022
Parnell Pharmaceuticals Holdings Ltd (OTC Pink ® Open Market: PARNF) ("Parnell") announced its intention to raise US$4.0 million through a backstopped rights offering at no charge (the "Rights Offering") for qualifying shareholders of record as of December 6, 2022 (the "Record Date").
-
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
6/21/2022
Parnell Pharmaceuticals Holdings Ltd, a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, 15th July 2022 at 8:30 a.m..
-
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd
12/21/2020
DW Healthcare Partners V, L.P. ("Purchaser"), announced today that it has commenced a cash tender offer for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S. $0.40 per share, net to the seller in cash without interest and less applicable wi
-
Parnell Pharmaceuticals Develops Nasal Spray to Fight Against COVID-19
9/2/2020
Parnell Pharmaceuticals has announced the development of an antiviral treatment to be used as a topical nasal spray as prophylaxis against COVID-19.
-
Parnell Pharmaceuticals Holdings Ltd Announces Business Update
12/23/2019
Parnell announces 2019 year-to-date revenue growth of 9% over the first 9 months of 2018, start of work on its new 2019 CMO contract, and updates to 2019 financial results.
-
Parnell Pharmaceuticals Holdings Ltd Announces New CDMO Agreement and Business Update
10/15/2019
Parnell announces a new contract manufacturing agreement for one animal health product and a memorandum of understanding for two additional products with a global multi-national;
-
Notice of Annual General Meeting and Explanatory Memorandum
4/30/2019
Parnell Pharmaceuticals Holdings Ltd, a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, 31 May 2019 at 9:00 a.m.
-
Parnell Pharmaceuticals Holdings Announces Business Results Update
5/25/2017
-
Parnell Pharmaceuticals Holdings To Report Business Update For The Three Months Ended March 31, 2017 On May 24, 2017
5/19/2017
-
Parnell Pharmaceuticals Holdings Release: Notice of Annual General Meeting And Explanatory Memorandum
4/28/2017
-
Parnell Pharmaceuticals Holdings Announces Financial Results For The Year Ended December 31, 2016
3/22/2017
-
Parnell Pharmaceuticals Holdings To Report Financial Results For Fiscal Year 2016 On March 22, 2017
2/24/2017
-
Parnell Pharmaceuticals Holdings Files Form 25, Voluntarily Delisting Its Shares From Nasdaq
12/20/2016
-
Parnell Pharmaceuticals Holdings Announces Intention To Move From The NASDAQ OMX Global Market And Expects To Move To The OTC Pink Open Market
12/12/2016
-
Parnell Pharmaceuticals Holdings Announces $20 Million Secured Term Loan Facility
11/23/2016
-
Parnell Pharmaceuticals Holdings Announces Financial Results For The Nine-Month Period Ended September 30, 2016
11/3/2016
-
Parnell Pharmaceuticals Holdings To Report Financial Results For The Nine Months Ended September 30, 2016 On November 2, 2016
10/28/2016
-
Parnell Pharmaceuticals Holdings Announces Financial Results For The Six-Month Period Ended June 30, 2016
8/4/2016